228. Bronchiolitis obliterans Clinical trials / Disease details
Clinical trials : 97 / Drugs : 118 - (DrugBank : 32) / Drug target genes : 33 - Drug target pathways : 156
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT00381147 (ClinicalTrials.gov) | July 2003 | 26/9/2006 | Use of Clarithromycin in Mustard-Induced Bronchiolitis | Phase III, Randomized, Double Blind Study of Low Dose Long Term Clarithromycin Versus Placebo in Treatment of Chronic Pulmonary Lesions Due to Sulfur Mustard | Bronchiolitis Obliterans;Acute Obliterating Bronchiolitis | Drug: Clarithromycin | Baqiyatallah Medical Sciences University | NULL | Completed | N/A | N/A | Male | Phase 3 | Iran, Islamic Republic of |